Illumina Inc ILMN

Technology Scientific & Technical Instruments

Illumina, Inc. is a provider of sequencing and array-based solutions for genetic and genomic analysis. The Company operates through two segments: Core Illumina and GRAIL. Its Core Illumina segment offers products and services that serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Its GRAIL segment is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed to accelerate and simplify genetic analysis. Its BaseSpace Informatics Suite integrates directly with its sequencing instruments, allowing customers to manage their biological sample and sequencing runs, process and analyze the raw genomic data, and derive results. Its BeadArray technology combines microscopic beads and a substrate in a proprietary manufacturing process to produce arrays that can perform various assays simultaneously.

NDAQ:ILMN - Post by User

Illumina Inc

<< Previous

Bullboard Posts

Next >>

Post by R_J_on Aug 02, 2020 7:15am

192 Views

Post# 31355031

End of Month - July 2020

End of the Month Report for July 2020 for Illumina Inc.
-
ILMN closed on 01/31/2020 at US$ 282.16
ILMN closed on 12/31/2019 at US$ 370.35
-
This is a 3.2% gain, a US$ 11.81 gain, for July
-
S&P 500 Index, @ 3271.1 gained 5.5% in July. [7.3% above its MA(200) @ 3048.6]
-
Two Hundred Day Moving Average [MA(200)] stuff.
ILMN's MA(200) ended July at US$318.40
ILMN is now 20.0% above its MA(200).
-
News Releases on the ILMN Website in July
-
Jul 16, 2020
Illumina to Announce Second Quarter 2020 Financial Results on Thursday, August 6, 2020
-
Jul 8, 2020
Illumina Launches TruSight Software Suite to Accelerate the Identification of Genetic Diseases
-
Who is in charge?
Francis A. DeSouza, CEO
-
RJ

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for May 22, 2024